This year, state lawmakers across the U.S. have introduced an unprecedented 160 bills to stem the rising cost of prescription drugs, and have enacted 37 into law.
States are pursuing a range of strategies to tackle drug costs including;
- allowing pharmacists to share lower cost drug options with consumers,
- enacting laws that authorize the wholesale purchase of drugs from Canada,
- and requiring drug manufacturers to provide additional data justifying price increases over specified thresholds.
For the past several years there has been increased interest and activity on legislation that relates to the pricing, payment, and costs associated with prescription drugs. Can more be done?
We conducted a survey amongst 4842 M3 Global Research members in Canada and the United States asking them:
"Should State legislators do more to curb the rising cost of prescription drugs?"
Both countries share similar opinions, you can find below what the M3 Global Research community answered to this question.
By registering with M3 Global Research you will receive the Monthly Pulse directly to your inbox and you will be able to share your opinion about relevant healthcare related issue and compare your thoughts with your colleagues around the World.